| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF133 ZNF136 ZNF600 ZNF142 ZFAT TSHZ2 ZNF257 ZNF175 ZNF451 ZNF566 ZFP1 ZNF813 KLF14 ZNF485 ZNF431 ZNF770 KLF18 LHX8 ZNF317 SKI ZNF471 ZBTB18 ZNF354C ZNF786 ZNF404 | 1.15e-10 | 1412 | 80 | 25 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF133 ZNF136 ZNF600 ZNF142 ZFAT ZNF257 ZNF175 ZNF566 ZFP1 ZNF813 KLF14 ZNF485 ZNF431 ZNF770 KLF18 LHX8 ZNF317 SKI ZNF471 ZNF354C ZNF786 ZNF404 | 3.78e-08 | 1459 | 80 | 22 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF136 ZNF600 ZFAT ZNF257 ZNF175 ZFP1 ZNF813 KLF14 ZNF485 ZNF431 ZNF770 KLF18 ZNF317 SKI ZNF471 ZNF354C ZNF786 | 6.91e-06 | 1244 | 80 | 17 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF136 ZNF600 ZFAT ZNF257 ZNF175 ZFP1 ZNF813 KLF14 ZNF485 ZNF431 ZNF770 KLF18 ZNF317 SKI ZNF471 ZNF354C ZNF786 | 9.17e-06 | 1271 | 80 | 17 | GO:0000987 |
| GeneOntologyMolecularFunction | platelet-derived growth factor receptor activity | 4.74e-05 | 3 | 80 | 2 | GO:0005017 | |
| GeneOntologyMolecularFunction | beta-adrenergic receptor kinase activity | 9.46e-05 | 4 | 80 | 2 | GO:0047696 | |
| GeneOntologyMolecularFunction | vascular endothelial growth factor binding | 2.35e-04 | 6 | 80 | 2 | GO:0038085 | |
| GeneOntologyMolecularFunction | sodium:bicarbonate symporter activity | 2.35e-04 | 6 | 80 | 2 | GO:0008510 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor kinase activity | 3.29e-04 | 7 | 80 | 2 | GO:0004703 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase binding | 6.81e-04 | 43 | 80 | 3 | GO:0043548 | |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 1.02e-03 | 12 | 80 | 2 | GO:0048407 | |
| GeneOntologyMolecularFunction | monoatomic cation:bicarbonate symporter activity | 1.20e-03 | 13 | 80 | 2 | GO:0140410 | |
| GeneOntologyMolecularFunction | platelet-derived growth factor receptor binding | 2.07e-03 | 17 | 80 | 2 | GO:0005161 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | 2.09e-03 | 709 | 80 | 9 | GO:0016773 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 2.27e-03 | 229 | 80 | 5 | GO:0003714 | |
| GeneOntologyMolecularFunction | protein kinase activity | 2.75e-03 | 600 | 80 | 8 | GO:0004672 | |
| GeneOntologyMolecularFunction | SUMO ligase activity | 2.87e-03 | 20 | 80 | 2 | GO:0061665 | |
| GeneOntologyBiologicalProcess | regulation of fibroblast proliferation | 9.39e-07 | 135 | 80 | 7 | GO:0048145 | |
| GeneOntologyBiologicalProcess | fibroblast proliferation | 2.93e-06 | 160 | 80 | 7 | GO:0048144 | |
| GeneOntologyBiologicalProcess | positive regulation of fibroblast proliferation | 1.99e-05 | 85 | 80 | 5 | GO:0048146 | |
| GeneOntologyBiologicalProcess | metanephric glomerulus morphogenesis | 4.45e-05 | 3 | 80 | 2 | GO:0072275 | |
| GeneOntologyBiologicalProcess | metanephric glomerular capillary formation | 4.45e-05 | 3 | 80 | 2 | GO:0072277 | |
| GeneOntologyBiologicalProcess | metanephric glomerulus vasculature morphogenesis | 4.45e-05 | 3 | 80 | 2 | GO:0072276 | |
| GeneOntologyBiologicalProcess | VEGF-activated platelet-derived growth factor receptor signaling pathway | 4.45e-05 | 3 | 80 | 2 | GO:0038086 | |
| GeneOntologyBiologicalProcess | positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway | 4.45e-05 | 3 | 80 | 2 | GO:0038091 | |
| GeneOntologyBiologicalProcess | retina development in camera-type eye | 1.71e-04 | 211 | 80 | 6 | GO:0060041 | |
| GeneOntologyBiologicalProcess | retina vasculature development in camera-type eye | 2.12e-04 | 30 | 80 | 3 | GO:0061298 | |
| GeneOntologyBiologicalProcess | glomerulus vasculature morphogenesis | 2.21e-04 | 6 | 80 | 2 | GO:0072103 | |
| GeneOntologyBiologicalProcess | glomerular capillary formation | 2.21e-04 | 6 | 80 | 2 | GO:0072104 | |
| GeneOntologyBiologicalProcess | positive regulation of smooth muscle cell migration | 3.06e-04 | 83 | 80 | 4 | GO:0014911 | |
| GeneOntologyBiologicalProcess | renal system vasculature morphogenesis | 3.08e-04 | 7 | 80 | 2 | GO:0061438 | |
| GeneOntologyBiologicalProcess | kidney vasculature morphogenesis | 3.08e-04 | 7 | 80 | 2 | GO:0061439 | |
| GeneOntologyBiologicalProcess | negative regulation of muscle contraction | 3.36e-04 | 35 | 80 | 3 | GO:0045932 | |
| GeneOntologyBiologicalProcess | positive regulation of vascular associated smooth muscle cell migration | 3.66e-04 | 36 | 80 | 3 | GO:1904754 | |
| GeneOntologyBiologicalProcess | metanephric glomerulus vasculature development | 4.10e-04 | 8 | 80 | 2 | GO:0072239 | |
| GeneOntologyBiologicalProcess | lung growth | 4.10e-04 | 8 | 80 | 2 | GO:0060437 | |
| Domain | zf-C2H2 | ZNF133 ZNF136 ZNF600 ZNF142 ZFAT ZNF775 TSHZ2 ZNF781 ZNF257 ZNF175 ZNF451 ZNF566 ZFP1 ZNF813 KLF14 ZNF485 ZNF431 ZNF770 ZNF317 ZNF471 ZBTB18 ZNF653 ZNF354C ZNF786 ZNF404 | 3.01e-17 | 693 | 78 | 25 | PF00096 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF133 ZNF136 ZNF600 ZNF142 ZFAT ZNF775 TSHZ2 ZNF781 ZNF257 ZNF175 ZNF451 ZNF566 ZFP1 ZNF813 KLF14 ZNF485 ZNF431 ZNF770 ZNF317 ZNF471 ZBTB18 ZNF653 ZNF354C ZNF786 ZNF404 | 4.09e-16 | 775 | 78 | 25 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF133 ZNF136 ZNF600 ZNF142 ZFAT ZNF775 TSHZ2 ZNF781 ZNF257 ZNF175 ZNF451 ZNF566 ZFP1 ZNF813 KLF14 ZNF485 ZNF431 ZNF770 ZNF317 ZNF471 ZBTB18 ZNF653 ZNF354C ZNF786 ZNF404 | 4.35e-16 | 777 | 78 | 25 | PS00028 |
| Domain | Znf_C2H2-like | ZNF133 ZNF136 ZNF600 ZNF142 ZFAT ZNF775 TSHZ2 ZNF781 ZNF257 ZNF175 ZNF451 ZNF566 ZFP1 ZNF813 KLF14 ZNF485 ZNF431 ZNF770 ZNF317 ZNF471 ZBTB18 ZNF653 ZNF354C ZNF786 ZNF404 | 7.60e-16 | 796 | 78 | 25 | IPR015880 |
| Domain | Znf_C2H2 | ZNF133 ZNF136 ZNF600 ZNF142 ZFAT ZNF775 TSHZ2 ZNF781 ZNF257 ZNF175 ZNF451 ZNF566 ZFP1 ZNF813 KLF14 ZNF485 ZNF431 ZNF770 ZNF317 ZNF471 ZBTB18 ZNF653 ZNF354C ZNF786 ZNF404 | 9.86e-16 | 805 | 78 | 25 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF133 ZNF136 ZNF600 ZNF142 ZFAT ZNF775 TSHZ2 ZNF781 ZNF257 ZNF175 ZNF451 ZNF566 ZFP1 ZNF813 KLF14 ZNF485 ZNF431 ZNF770 ZNF317 ZNF471 ZBTB18 ZNF653 ZNF354C ZNF786 ZNF404 | 1.07e-15 | 808 | 78 | 25 | SM00355 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF133 ZNF136 ZNF600 ZNF142 ZFAT ZNF775 ZNF781 ZNF257 ZNF175 ZNF566 ZFP1 ZNF813 KLF14 ZNF485 ZNF431 ZNF770 ZNF317 ZNF471 ZBTB18 ZNF653 ZNF354C ZNF786 ZNF404 | 4.54e-15 | 694 | 78 | 23 | IPR013087 |
| Domain | - | ZNF133 ZNF136 ZNF600 ZNF142 ZFAT ZNF775 ZNF781 ZNF257 ZNF175 ZNF566 ZFP1 ZNF813 ZNF485 ZNF431 ZNF770 ZNF317 ZNF471 ZBTB18 ZNF653 ZNF354C ZNF786 ZNF404 | 3.21e-14 | 679 | 78 | 22 | 3.30.160.60 |
| Domain | KRAB | ZNF133 ZNF136 ZNF257 ZNF175 ZNF566 ZFP1 ZNF813 ZNF485 ZNF431 ZNF317 ZNF471 ZNF354C ZNF786 ZNF404 | 2.37e-10 | 358 | 78 | 14 | PS50805 |
| Domain | KRAB | ZNF133 ZNF136 ZNF257 ZNF175 ZNF566 ZFP1 ZNF813 ZNF485 ZNF431 ZNF317 ZNF471 ZNF354C ZNF786 ZNF404 | 2.37e-10 | 358 | 78 | 14 | PF01352 |
| Domain | KRAB | ZNF133 ZNF136 ZNF257 ZNF175 ZNF566 ZFP1 ZNF813 ZNF485 ZNF431 ZNF317 ZNF471 ZNF354C ZNF786 ZNF404 | 3.52e-10 | 369 | 78 | 14 | SM00349 |
| Domain | KRAB | ZNF133 ZNF136 ZNF257 ZNF175 ZNF566 ZFP1 ZNF813 ZNF485 ZNF431 ZNF317 ZNF471 ZNF354C ZNF786 ZNF404 | 3.65e-10 | 370 | 78 | 14 | IPR001909 |
| Domain | zf-C2H2_6 | ZNF133 ZNF136 ZNF600 ZNF566 ZNF813 ZNF431 ZNF770 ZNF317 ZNF354C ZNF404 | 7.16e-07 | 314 | 78 | 10 | PF13912 |
| Domain | Ribosomal_L26 | 1.72e-05 | 2 | 78 | 2 | PF16906 | |
| Domain | Ribosomal_L26/L24P_euk/arc | 1.72e-05 | 2 | 78 | 2 | IPR005756 | |
| Domain | Ribosomal_L24/26_CS | 5.15e-05 | 3 | 78 | 2 | IPR005825 | |
| Domain | RIBOSOMAL_L24 | 5.15e-05 | 3 | 78 | 2 | PS01108 | |
| Domain | Tyr_kinase_CSF1/PDGF_rcpt | 2.55e-04 | 6 | 78 | 2 | IPR016243 | |
| Domain | GPCR_kinase | 3.57e-04 | 7 | 78 | 2 | IPR000239 | |
| Domain | ANION_EXCHANGER_2 | 3.57e-04 | 7 | 78 | 2 | PS00220 | |
| Domain | ANION_EXCHANGER_1 | 3.57e-04 | 7 | 78 | 2 | PS00219 | |
| Domain | KOW | 3.57e-04 | 7 | 78 | 2 | SM00739 | |
| Domain | Kinase-like_dom | 4.20e-04 | 542 | 78 | 9 | IPR011009 | |
| Domain | Tyr_kinase_rcpt_3_CS | 4.74e-04 | 8 | 78 | 2 | IPR001824 | |
| Domain | RECEPTOR_TYR_KIN_III | 4.74e-04 | 8 | 78 | 2 | PS00240 | |
| Domain | Band3_cytoplasmic_dom | 6.08e-04 | 9 | 78 | 2 | IPR013769 | |
| Domain | Band_3_cyto | 6.08e-04 | 9 | 78 | 2 | PF07565 | |
| Domain | - | 6.08e-04 | 9 | 78 | 2 | 3.40.1100.10 | |
| Domain | HCO3_cotransp | 7.58e-04 | 10 | 78 | 2 | PF00955 | |
| Domain | HCO3_transpt_C | 7.58e-04 | 10 | 78 | 2 | IPR011531 | |
| Domain | PTrfase/Anion_transptr | 7.58e-04 | 10 | 78 | 2 | IPR016152 | |
| Domain | HCO3_transpt_euk | 7.58e-04 | 10 | 78 | 2 | IPR003020 | |
| Domain | KOW | 9.24e-04 | 11 | 78 | 2 | IPR005824 | |
| Domain | KOW | 9.24e-04 | 11 | 78 | 2 | PF00467 | |
| Domain | DOCK_C | 9.24e-04 | 11 | 78 | 2 | IPR010703 | |
| Domain | DHR-1_domain | 9.24e-04 | 11 | 78 | 2 | IPR027007 | |
| Domain | DHR_2 | 9.24e-04 | 11 | 78 | 2 | PS51651 | |
| Domain | DHR_1 | 9.24e-04 | 11 | 78 | 2 | PS51650 | |
| Domain | DOCK-C2 | 9.24e-04 | 11 | 78 | 2 | PF14429 | |
| Domain | DHR-2 | 9.24e-04 | 11 | 78 | 2 | IPR027357 | |
| Domain | DHR-2 | 9.24e-04 | 11 | 78 | 2 | PF06920 | |
| Domain | DOCK | 9.24e-04 | 11 | 78 | 2 | IPR026791 | |
| Domain | Protein_kinase_ATP_BS | 1.03e-03 | 379 | 78 | 7 | IPR017441 | |
| Domain | AGC-kinase_C | 1.66e-03 | 56 | 78 | 3 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 1.66e-03 | 56 | 78 | 3 | PS51285 | |
| Domain | S_TK_X | 1.66e-03 | 56 | 78 | 3 | SM00133 | |
| Domain | Translation_prot_SH3-like | 2.25e-03 | 17 | 78 | 2 | IPR008991 | |
| Domain | Rib_L2_dom2 | 2.52e-03 | 18 | 78 | 2 | IPR014722 | |
| Domain | - | 2.52e-03 | 18 | 78 | 2 | 2.30.30.30 | |
| Domain | PROTEIN_KINASE_ATP | 3.04e-03 | 459 | 78 | 7 | PS00107 | |
| Domain | S_TKc | 3.89e-03 | 359 | 78 | 6 | SM00220 | |
| Domain | Prot_kinase_dom | 4.31e-03 | 489 | 78 | 7 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 4.50e-03 | 493 | 78 | 7 | PS50011 | |
| Domain | RGS | 9.37e-03 | 35 | 78 | 2 | PF00615 | |
| Domain | RGS | 9.37e-03 | 35 | 78 | 2 | SM00315 | |
| Domain | RGS | 9.90e-03 | 36 | 78 | 2 | PS50132 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | ZNF133 ZNF136 ZNF600 ZNF775 TJP1 ZNF257 ZNF175 ZNF566 ZFP1 ZNF485 ZNF431 ZNF770 ZNF317 SKI ZNF471 ZNF354C ZNF786 | 1.24e-05 | 1387 | 55 | 17 | M734 |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | GLIPR1 SART1 GDPD1 ZNF142 SLC4A7 LIMD1 PDGFRB TJP1 ZNF451 ZNF566 ZNF813 DOCK7 ZNF485 FADS2 PRKDC ZNF317 NONO THAP12 SLX4 | 2.99e-11 | 1203 | 81 | 19 | 29180619 |
| Pubmed | 2.31e-07 | 181 | 81 | 7 | 37372979 | ||
| Pubmed | RPL26 ALMS1 LIMD1 MYO5A RPL26L1 ZNF451 ZNF485 MRPS5 ZNF770 INO80 ZMIZ1 LHX8 SKI ZNF471 SLX4 | 9.48e-07 | 1429 | 81 | 15 | 35140242 | |
| Pubmed | The P-body component USP52/PAN2 is a novel regulator of HIF1A mRNA stability. | 1.02e-06 | 328 | 81 | 8 | 23398456 | |
| Pubmed | 1.44e-06 | 10 | 81 | 3 | 1869533 | ||
| Pubmed | Death receptors DR6 and TROY regulate brain vascular development. | 1.98e-06 | 11 | 81 | 3 | 22340501 | |
| Pubmed | SART1 ZNF775 LIMD1 BTBD7 ZNF175 ZNF451 ZNF566 LHX8 ZNF653 ZNF354C ZNF786 | 2.75e-06 | 808 | 81 | 11 | 20412781 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 8638670 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 19333949 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 17363728 | ||
| Pubmed | Combined anti-PDGFRalpha and PDGFRbeta targeting in non-small cell lung cancer. | 5.36e-06 | 2 | 81 | 2 | 19115205 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 17145809 | ||
| Pubmed | The fusion proteins TEL-PDGFRbeta and FIP1L1-PDGFRalpha escape ubiquitination and degradation. | 5.36e-06 | 2 | 81 | 2 | 19644140 | |
| Pubmed | Platelet-derived growth factor receptor expression and activation in choroid plexus tumors. | 5.36e-06 | 2 | 81 | 2 | 19717644 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 19843560 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 8586421 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 33060647 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 32737331 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 11544480 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 7523122 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 22431518 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 8035170 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 11782318 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 17344284 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 20489144 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 22661233 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 1847074 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 20107158 | ||
| Pubmed | Platelet-derived growth factor receptor: current views of the two-subunit model. | 5.36e-06 | 2 | 81 | 2 | 2161888 | |
| Pubmed | Roles of platelet-derived growth factor in the developing and mature nervous systems. | 5.36e-06 | 2 | 81 | 2 | 9233543 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 18331602 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 15271984 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 18288404 | ||
| Pubmed | Calcitriol inhibits growth response to Platelet-Derived Growth Factor-BB in human prostate cells. | 5.36e-06 | 2 | 81 | 2 | 15862965 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 22697462 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 28129672 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 14624252 | ||
| Pubmed | PDGF receptors in tumor biology: prognostic and predictive potential. | 5.36e-06 | 2 | 81 | 2 | 25145436 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 19035305 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 8617789 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 7665222 | ||
| Pubmed | Altered airway and cardiac responses in mice lacking G protein-coupled receptor kinase 3. | 5.36e-06 | 2 | 81 | 2 | 10198406 | |
| Pubmed | A new look at platelet-derived growth factor in renal disease. | 5.36e-06 | 2 | 81 | 2 | 18077793 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 2554309 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 2531695 | ||
| Pubmed | Survival-associated heterogeneity of marker-defined perivascular cells in colorectal cancer. | 5.36e-06 | 2 | 81 | 2 | 27248825 | |
| Pubmed | G-protein coupled receptor kinase 2 and 3 expression in human detrusor cultured smooth muscle cells. | 5.36e-06 | 2 | 81 | 2 | 11762794 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 24763086 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 19839721 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 17448020 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 2542288 | ||
| Pubmed | Different PDGF Receptor Dimers Drive Distinct Migration Modes of the Mouse Skin Fibroblast. | 5.36e-06 | 2 | 81 | 2 | 30485861 | |
| Pubmed | Platelet-derived growth factor receptor expression and amplification in choroid plexus carcinomas. | 5.36e-06 | 2 | 81 | 2 | 18157090 | |
| Pubmed | Reduced expression of PDGF and PDGF receptors during impaired wound healing. | 5.36e-06 | 2 | 81 | 2 | 9242497 | |
| Pubmed | Postnatal tendon growth and remodeling require platelet-derived growth factor receptor signaling. | 5.36e-06 | 2 | 81 | 2 | 29341790 | |
| Pubmed | Autocrine PDGFR signaling promotes mammary cancer metastasis. | 5.36e-06 | 2 | 81 | 2 | 16741576 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 15380338 | ||
| Pubmed | 6.28e-06 | 51 | 81 | 4 | 11853319 | ||
| Pubmed | 8.08e-06 | 17 | 81 | 3 | 7557990 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 10754297 | ||
| Pubmed | Expression of CAF-Related Proteins Is Associated with Histologic Grade of Breast Phyllodes Tumor. | 1.60e-05 | 3 | 81 | 2 | 27881889 | |
| Pubmed | Expression of tyrosine kinase receptors in malignant midgut carcinoid tumors. | 1.60e-05 | 3 | 81 | 2 | 17047316 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 35508129 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 10085131 | ||
| Pubmed | Cell migration is regulated by platelet-derived growth factor receptor endocytosis. | 1.60e-05 | 3 | 81 | 2 | 19528233 | |
| Pubmed | Embryonic mouse testis development: role of platelet derived growth factor (PDGF-BB). | 1.60e-05 | 3 | 81 | 2 | 15254974 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 22940072 | ||
| Pubmed | Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. | 1.60e-05 | 3 | 81 | 2 | 7761854 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 21574155 | ||
| Pubmed | The N-termini of GRK2 and GRK3 simulate the stimulating effects of RKIP on β-adrenoceptors. | 1.60e-05 | 3 | 81 | 2 | 31604529 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 29158445 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 23146028 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 29380207 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 12130708 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 18519768 | ||
| Pubmed | Protein expression of KIT and gene mutation of c-kit and PDGFRs in Ewing sarcomas. | 1.60e-05 | 3 | 81 | 2 | 17298867 | |
| Pubmed | Conservation in sequence and affinity of human and rodent PDGF ligands and receptors. | 1.60e-05 | 3 | 81 | 2 | 8318539 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 21590454 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 23567961 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 11046132 | ||
| Pubmed | Dysregulation of Amphiregulin stimulates the pathogenesis of cystic lymphangioma. | 1.60e-05 | 3 | 81 | 2 | 33941693 | |
| Pubmed | Pdgfra and Pdgfrb genetically interact during craniofacial development. | 1.60e-05 | 3 | 81 | 2 | 26971580 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 25502837 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 10347229 | ||
| Pubmed | Expression of c-kit and platelet-derived growth factor receptors in ovarian granulosa cell tumors. | 1.60e-05 | 3 | 81 | 2 | 18492696 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 24022915 | ||
| Pubmed | PDGFR-β Plays a Key Role in the Ectopic Migration of Neuroblasts in Cerebral Stroke. | 1.60e-05 | 3 | 81 | 2 | 26435273 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 15791568 | ||
| Pubmed | Platelet-derived growth factor (PDGF) receptors in the developing mouse optic pathway. | 1.60e-05 | 3 | 81 | 2 | 8011581 | |
| Pubmed | Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. | 1.60e-05 | 3 | 81 | 2 | 9211853 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 12381737 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 16971512 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 19302534 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 10733900 | ||
| Pubmed | Adaptor protein Lnk binds to PDGF receptor and inhibits PDGF-dependent signaling. | 1.60e-05 | 3 | 81 | 2 | 21310211 | |
| Pubmed | A novel function of p53: a gatekeeper of retinal detachment. | 1.60e-05 | 3 | 81 | 2 | 22901751 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 18184658 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 27638178 | ||
| Pubmed | 1.66e-05 | 65 | 81 | 4 | 23453885 | ||
| Pubmed | 2.38e-05 | 24 | 81 | 3 | 20371769 | ||
| Interaction | RNF4 interactions | GLIPR1 SART1 GDPD1 ZNF142 SLC4A7 LIMD1 PDGFRB TJP1 ZNF451 ZNF566 ZNF813 DOCK7 ZNF485 FADS2 PRKDC ZNF317 NONO THAP12 SLX4 | 1.58e-06 | 1412 | 79 | 19 | int:RNF4 |
| Interaction | ZNF467 interactions | 6.56e-06 | 179 | 79 | 7 | int:ZNF467 | |
| Interaction | CACNG5 interactions | 1.98e-05 | 41 | 79 | 4 | int:CACNG5 | |
| Interaction | BRSK2 interactions | 2.91e-05 | 91 | 79 | 5 | int:BRSK2 | |
| Interaction | E4F1 interactions | 4.81e-05 | 101 | 79 | 5 | int:E4F1 | |
| Cytoband | 11q13.1 | 1.95e-04 | 63 | 81 | 3 | 11q13.1 | |
| Cytoband | 5q35 | 7.59e-04 | 23 | 81 | 2 | 5q35 | |
| Cytoband | 2p13 | 7.59e-04 | 23 | 81 | 2 | 2p13 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF133 ZNF136 ZNF600 ZNF142 ZFAT ZNF775 TSHZ2 ZNF781 ZNF257 ZNF175 ZNF451 ZNF566 ZFP1 ZNF813 KLF14 ZNF485 ZNF431 ZNF770 ZNF317 ZNF471 ZBTB18 ZNF653 ZNF354C ZNF786 ZNF404 | 3.67e-19 | 718 | 63 | 25 | 28 |
| GeneFamily | Zinc fingers C2H2-type|Kruppel like factors | 1.76e-03 | 18 | 63 | 2 | 624 | |
| ToppCell | (5)_Fibroblast-D|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.85e-08 | 199 | 81 | 7 | 3f415620ad8b8d8c6871e1353e13f87b281fcc0e | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-06 | 184 | 81 | 6 | 9c20b50f8d6ac689d41d5440c835f9db8d04758b | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.08e-06 | 184 | 81 | 6 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-06 | 184 | 81 | 6 | 31dbe6119a3bcd266ae5e9b340c853d9ff680dce | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-06 | 192 | 81 | 6 | 4022f208eb5db760abd0aac782a25e8ab63efc64 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 1.48e-06 | 194 | 81 | 6 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A2|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.48e-06 | 133 | 81 | 5 | 8ff1cf0ea1fc33fe8384c0e65c1ee1853b25a2ae | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.05e-06 | 150 | 81 | 5 | 909ccab92855f5f049dc29593aadab1ea973297b | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-Treg|ICU-NoSEP / Disease, Lineage and Cell Type | 1.07e-05 | 159 | 81 | 5 | d065ec02a4f3672ba53d4fea66029f1ce68f367f | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 168 | 81 | 5 | 4ae9e9d93bcd6f4d5815e57fd5afa7a3398a0ec1 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 168 | 81 | 5 | 04e168fe1d6f5f9e3d3bf9d7c13e800e3594868a | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 169 | 81 | 5 | 454b92b9b67299a64278c010db033ca5b9d217a0 | |
| ToppCell | PND01-03-samps-Mesenchymal-Pericyte-pericyte_F|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.47e-05 | 170 | 81 | 5 | 71718dcebd48105994c313bb55babc70301170a0 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-05 | 173 | 81 | 5 | 2415b6ff49f334da570577d4e93484d024a3dbd5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-05 | 173 | 81 | 5 | 2acd0693a2dfe04e3c1b2125ea63efe92d13150b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.89e-05 | 179 | 81 | 5 | b35a7f8115c997c390201da01d7cb10b10769aec | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.99e-05 | 181 | 81 | 5 | 47dce04db3392333eb2f7b9b24c32e6740d2d02f | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.99e-05 | 181 | 81 | 5 | 19103221c3a5a16b16378348004b2c50caee4f01 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 181 | 81 | 5 | 1db1eb7d330a7e5090994007ae287e11f0a74450 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 181 | 81 | 5 | 06174ce9240c9261c0f51a1b0d875335d60722e5 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.16e-05 | 184 | 81 | 5 | 9cc5c588f7c6631b3fb8a522214a09ca32947e72 | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 2.21e-05 | 185 | 81 | 5 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.21e-05 | 185 | 81 | 5 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.27e-05 | 186 | 81 | 5 | 77bebf576eb9b96ecb4fefb8a82a31aaaa917fc0 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.27e-05 | 186 | 81 | 5 | 13bc41c60fd628af31899a5e8b480e06cc4781be | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.39e-05 | 188 | 81 | 5 | de6f4889e0c5f39fbbaefd85526f645c6afa09d5 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.65e-05 | 192 | 81 | 5 | 9333aba0d04203ccccad78d82bf6359922f810a7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-05 | 193 | 81 | 5 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.71e-05 | 193 | 81 | 5 | cf2461af78f65616ce40d552ee9452295e3895ed | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.71e-05 | 193 | 81 | 5 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.71e-05 | 193 | 81 | 5 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-05 | 195 | 81 | 5 | d8ebb94f30d4a655d6b29dd6a3076be2403d2356 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-05 | 195 | 81 | 5 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-05 | 195 | 81 | 5 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-05 | 195 | 81 | 5 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 2.99e-05 | 197 | 81 | 5 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.99e-05 | 197 | 81 | 5 | 6668f0da54f3bf96769275e668cd57e00b8a5ef9 | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-Treg|ICU-NoSEP / Disease, condition lineage and cell class | 3.07e-05 | 198 | 81 | 5 | 1ed4dfe5565328cb0f7ef31e6b2f67dfbdf3e2ac | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 3.07e-05 | 198 | 81 | 5 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D-|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.14e-05 | 199 | 81 | 5 | 5a425e7d11c5911ff5855c27a7f058a7ed7abbb0 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.14e-05 | 199 | 81 | 5 | 9b2262edbdec89166d895ab97527e0ee5f9b6010 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.14e-05 | 199 | 81 | 5 | 66545eb7f65e450b742628fd431956e13330a0d3 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.14e-05 | 199 | 81 | 5 | 251b3643dcd8f4645b17101bd716e66f12a20e88 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-F|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.14e-05 | 199 | 81 | 5 | b877c1d24357249781032e99d4237f72789cc9b8 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.14e-05 | 199 | 81 | 5 | 117f4f43b6c06dda553799b1063e827bce697370 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-F-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.14e-05 | 199 | 81 | 5 | e32fa66f3361474088ba1dd58574822537950d59 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Fibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 3.22e-05 | 200 | 81 | 5 | 8d75ce89393df452defacf2ec9a5bd4b7708afbb | |
| ToppCell | Neuronal-Excitatory-eB(RORB)-SEMA3E-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.22e-05 | 200 | 81 | 5 | 1a3d29a580d1b405a74869a1da3e818c581fc559 | |
| ToppCell | Neuronal-Excitatory-eB(RORB)-SEMA3E---L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.22e-05 | 200 | 81 | 5 | 6f9ed8fe9cda91185c3a1a675353e11b8fec6ef1 | |
| ToppCell | Neuronal-Excitatory-eB(RORB)-SEMA3E--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.22e-05 | 200 | 81 | 5 | 86705dfc05b3e1576543b93883c88fb55b742855 | |
| ToppCell | Neuronal-Excitatory-eB(RORB)-SEMA3E|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.22e-05 | 200 | 81 | 5 | db194b4f524fd008b3c5b4b6014b436190a1b87a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.24e-04 | 140 | 81 | 4 | 7b359bfbd404ab06d799048252f4985d85852048 | |
| ToppCell | E12.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.35e-04 | 143 | 81 | 4 | cc396b81a5e47d78c2d1cb49d682391376b63476 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-04 | 150 | 81 | 4 | 8645b9c7f9511ed6cc9afe04440c2873a3094150 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-04 | 151 | 81 | 4 | c743dc8758416a4f562d60c8fd2df7e659ab6951 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.79e-04 | 154 | 81 | 4 | dd3d34f065820e706515a13619f19a5b12734c8e | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.79e-04 | 154 | 81 | 4 | 4bfda1c41efbb86d829b3797d1168bf2587c3c97 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-04 | 157 | 81 | 4 | ec433d2fe827abdb647be4176c231b7052482b6f | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-04 | 158 | 81 | 4 | 90ca742739a208d457db087655ba3d1c18a9da57 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-04 | 159 | 81 | 4 | 5ca96db4281abb5f646150ccf36adc66ab201c78 | |
| ToppCell | 5'-Adult-Appendix-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.17e-04 | 162 | 81 | 4 | ded08da888d8c481f0f96d1e0bfd03d617966910 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-04 | 163 | 81 | 4 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-04 | 163 | 81 | 4 | fd243ca223079033be480a24817a399f281fa4d4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.28e-04 | 164 | 81 | 4 | f6a961fa2002da7d9679f32af99e1314c0593ef9 | |
| ToppCell | facs-Trachea-18m-Epithelial-glandular_epithelial-lung_secretory_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.28e-04 | 164 | 81 | 4 | cdb8cd2d6b369189ea77e4946738e2816d502e03 | |
| ToppCell | facs-Trachea-18m-Epithelial-glandular_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.28e-04 | 164 | 81 | 4 | 5dbfcdd450f652b16d97da53b528d4584b0eabcf | |
| ToppCell | facs-Trachea-18m-Epithelial-glandular_epithelial-lung_secretory_cell-mucous|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.28e-04 | 164 | 81 | 4 | f1423f4434af4af9c60c8a5b0b0abec4a7df9401 | |
| ToppCell | CV-Mild-3|Mild / Virus stimulation, Condition and Cluster | 2.38e-04 | 166 | 81 | 4 | 5599f90fc0e15a3670b03187085eba91228390a2 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-2|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 2.49e-04 | 168 | 81 | 4 | c70bf73bb800e4722cedc35bbc17ea3113d1012d | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 2.49e-04 | 168 | 81 | 4 | 968405ea56f7d001ef83ff9274610923c3b2d55d | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.49e-04 | 168 | 81 | 4 | 27cdf5cfa1d906868cfd60fdfab3cd51f3b3602f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.79e-04 | 173 | 81 | 4 | ee972d9cc68755926512fd3bbe1267098c67cd94 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.85e-04 | 174 | 81 | 4 | 9d22a554617a93701d0945de63cc3e7b24322c40 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-04 | 174 | 81 | 4 | 763ca53339d9e236da8463f2a9d1bd39d4385d75 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-04 | 174 | 81 | 4 | a0a059bb2a64d7011e206db2ebcdf3eb655a925a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.85e-04 | 174 | 81 | 4 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-04 | 174 | 81 | 4 | 7cd6f9103133f8d7b90f9ff4b3b0b078cf554542 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.91e-04 | 175 | 81 | 4 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | Pericytes-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 2.91e-04 | 175 | 81 | 4 | ddf721023a7afc8085c5de17aa254a6575444c0f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.98e-04 | 176 | 81 | 4 | e9152defb4fd41267fb33c42c01fd0c683280783 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.98e-04 | 176 | 81 | 4 | a4d269075aa0efc46fa251b379f334e50c69391d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.98e-04 | 176 | 81 | 4 | cc6f65a7d2c622841c9d1ab3755586039d4ccc4d | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.04e-04 | 177 | 81 | 4 | f360f7099570d248531897b96e0de282e58f59e9 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-04 | 177 | 81 | 4 | dbdbdc8ed9ef0b529694242ef9f9f07a42e16005 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.04e-04 | 177 | 81 | 4 | 7e799333307448c6a94d1f33dbc59c543336f45e | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 3.11e-04 | 178 | 81 | 4 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-04 | 178 | 81 | 4 | 742ee0cb8cb585a5e34bd5b20aebe9bb99756e0c | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.11e-04 | 178 | 81 | 4 | 8f31b3fac51591f7f2bcb898c07708b3e9f93a16 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-04 | 178 | 81 | 4 | 416f85e51f45ec7949451fd47611a84e33e87245 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.17e-04 | 179 | 81 | 4 | 111b1084f73306bdeffaaf240e7dbb4f5bf33de1 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.17e-04 | 179 | 81 | 4 | d3d3a9afaac28fa4f2c448c73d79bcbbbea088d7 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.24e-04 | 180 | 81 | 4 | 62511d76d24b836839c3dcc2bf30485ffe9401e2 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.24e-04 | 180 | 81 | 4 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Mesenchymal_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.31e-04 | 181 | 81 | 4 | 7e3bcfa2ba5b98a7df5854aa6e7a31e9a71faa8a | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-04 | 181 | 81 | 4 | 35eefd874a892eaf21f24fdce89e7ea3b8ee285f | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.31e-04 | 181 | 81 | 4 | 9c157de9d3403e092c907599f2a2c16db5b21131 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-04 | 181 | 81 | 4 | e4c3e0eae9f21e78b5dd18cf017bd041ffc8c968 | |
| ToppCell | Pericytes-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 3.31e-04 | 181 | 81 | 4 | ff445a8e56522e57e27405184d123cf905caf8cc | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.31e-04 | 181 | 81 | 4 | eea943fdcbef0bbaa8578f3296923e874893b405 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.31e-04 | 181 | 81 | 4 | b7c85fbef3c06d5dc32a2a58f8d3dfabf1d79d9f | |
| Drug | 3-pyridyl)urea | 1.25e-05 | 2 | 81 | 2 | CID000202697 | |
| Drug | isocurcumenol | 1.25e-05 | 2 | 81 | 2 | CID005255901 | |
| Drug | 4-nitrophenylurea | 1.25e-05 | 2 | 81 | 2 | CID000313520 | |
| Drug | 5,7-Dmpq | 1.25e-05 | 2 | 81 | 2 | CID000003139 | |
| Drug | tyrphostin AG1296 | 1.81e-05 | 44 | 81 | 4 | CID000002049 | |
| Drug | LS-64027 | 3.74e-05 | 3 | 81 | 2 | CID000167812 | |
| Drug | 6,7-dimethoxyquinoline | 3.74e-05 | 3 | 81 | 2 | CID010856252 | |
| Drug | Becaplermin | 3.74e-05 | 3 | 81 | 2 | DB00102 | |
| Drug | AC1NSUA7 | 3.74e-05 | 3 | 81 | 2 | CID005316441 | |
| Drug | trapidil | 5.09e-05 | 57 | 81 | 4 | CID000005531 | |
| Disease | emphysema imaging measurement | 4.65e-05 | 146 | 79 | 5 | EFO_0007626 | |
| Disease | oligohydramnios (biomarker_via_orthology) | 7.04e-05 | 5 | 79 | 2 | DOID:12215 (biomarker_via_orthology) | |
| Disease | level of Phosphatidylcholine (18:2_18:2) in blood serum | 1.05e-04 | 6 | 79 | 2 | OBA_2045106 | |
| Disease | level of Phosphatidylinositol (18:1_18:2) in blood serum | 1.05e-04 | 6 | 79 | 2 | OBA_2045160 | |
| Disease | 1-stearoyl-2-linoleoyl-GPC (18:0/18:2) measurement | 1.05e-04 | 6 | 79 | 2 | EFO_0800404 | |
| Disease | level of Phosphatidylcholine (16:0_18:0) in blood serum | 1.05e-04 | 6 | 79 | 2 | OBA_2045069 | |
| Disease | 1-palmitoyl-2-linoleoyl-GPI (16:0/18:2) measurement | 1.47e-04 | 7 | 79 | 2 | EFO_0800609 | |
| Disease | 1-palmitoyl-2-linoleoyl-GPC (16:0/18:2) measurement | 1.96e-04 | 8 | 79 | 2 | EFO_0800610 | |
| Disease | Leydig cell tumor (is_marker_for) | 1.96e-04 | 8 | 79 | 2 | DOID:2696 (is_marker_for) | |
| Disease | 1-palmitoyl-2-stearoyl-GPC (16:0/18:0) measurement | 1.96e-04 | 8 | 79 | 2 | EFO_0800396 | |
| Disease | level of Phosphatidylinositol (16:0_18:2) in blood serum | 1.96e-04 | 8 | 79 | 2 | OBA_2045153 | |
| Disease | blindness (implicated_via_orthology) | 1.96e-04 | 8 | 79 | 2 | DOID:1432 (implicated_via_orthology) | |
| Disease | level of Phosphatidylcholine (18:1_18:1) in blood serum | 1.96e-04 | 8 | 79 | 2 | OBA_2045099 | |
| Disease | 1-palmitoyl-2-oleoyl-GPI (16:0/18:1) measurement | 2.52e-04 | 9 | 79 | 2 | EFO_0800439 | |
| Disease | 1-palmitoyl-2-arachidonoyl-GPI (16:0/20:4) measurement | 2.52e-04 | 9 | 79 | 2 | EFO_0800412 | |
| Disease | 1-stearoyl-2-oleoyl-GPI (18:0/18:1) measurement | 3.14e-04 | 10 | 79 | 2 | EFO_0800469 | |
| Disease | oleoyl-linoleoyl-glycerol (18:1/18:2) [2] measurement | 3.14e-04 | 10 | 79 | 2 | EFO_0800333 | |
| Disease | level of Phosphatidylcholine (16:0_20:3) in blood serum | 3.14e-04 | 10 | 79 | 2 | OBA_2045075 | |
| Disease | level of Phosphatidylinositol (16:0_18:1) in blood serum | 4.59e-04 | 12 | 79 | 2 | OBA_2045152 | |
| Disease | level of Phosphatidylinositol (18:0_20:3) in blood serum | 4.59e-04 | 12 | 79 | 2 | OBA_2045157 | |
| Disease | cholesteryl ester 20:2 measurement | 4.59e-04 | 12 | 79 | 2 | EFO_0021440 | |
| Disease | level of Phosphatidylinositol (18:1_18:1) in blood serum | 5.42e-04 | 13 | 79 | 2 | OBA_2045159 | |
| Disease | 1-stearoyl-2-linoleoyl-GPI (18:0/18:2) measurement | 5.42e-04 | 13 | 79 | 2 | EFO_0800413 | |
| Disease | phospholipids in large VLDL measurement | 6.23e-04 | 62 | 79 | 3 | EFO_0022169 | |
| Disease | total lipids in very large VLDL measurement | 6.23e-04 | 62 | 79 | 3 | EFO_0022313 | |
| Disease | 1-stearoyl-2-dihomo-linolenoyl-GPI (18:0/20:3n3 or 6) measurement | 6.31e-04 | 14 | 79 | 2 | EFO_0022085 | |
| Disease | level of Phosphatidylcholine (18:1_18:2) in blood serum | 6.31e-04 | 14 | 79 | 2 | OBA_2045100 | |
| Disease | anemia (implicated_via_orthology) | 7.27e-04 | 15 | 79 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | total lipids in large VLDL | 7.82e-04 | 67 | 79 | 3 | EFO_0022175 | |
| Disease | triglycerides to phosphoglycerides ratio | 8.17e-04 | 68 | 79 | 3 | EFO_0022327 | |
| Disease | free cholesterol in large VLDL measurement | 8.17e-04 | 68 | 79 | 3 | EFO_0022265 | |
| Disease | 1-stearoyl-2-arachidonoyl-GPI (18:0/20:4) measurement | 8.29e-04 | 16 | 79 | 2 | EFO_0800184 | |
| Disease | level of Phosphatidylcholine (18:0_18:2) in blood serum | 8.29e-04 | 16 | 79 | 2 | OBA_2045090 | |
| Disease | Manic Disorder | 9.26e-04 | 71 | 79 | 3 | C0024713 | |
| Disease | hyperglycemia (implicated_via_orthology) | 9.38e-04 | 17 | 79 | 2 | DOID:4195 (implicated_via_orthology) | |
| Disease | triglycerides to total lipids in small HDL percentage | 9.64e-04 | 72 | 79 | 3 | EFO_0022336 | |
| Disease | level of Phosphatidylinositol (18:0_18:1) in blood serum | 1.05e-03 | 18 | 79 | 2 | OBA_2045155 | |
| Disease | level of Phosphatidylcholine (15:0_18:2) in blood serum | 1.05e-03 | 18 | 79 | 2 | OBA_2045065 | |
| Disease | Crohn's disease | 1.19e-03 | 441 | 79 | 6 | EFO_0000384 | |
| Disease | Manic | 1.22e-03 | 78 | 79 | 3 | C0338831 | |
| Disease | Depression, Bipolar | 1.26e-03 | 79 | 79 | 3 | C0005587 | |
| Disease | level of Phosphatidylcholine (16:0_18:2) in blood serum | 1.30e-03 | 20 | 79 | 2 | OBA_2045071 | |
| Disease | longitudinal BMI measurement | 1.40e-03 | 82 | 79 | 3 | EFO_0005937 | |
| Disease | level of Phosphatidylinositol (18:0_18:2) in blood serum | 1.44e-03 | 21 | 79 | 2 | OBA_2045156 | |
| Disease | cholesteryl ester measurement, high density lipoprotein cholesterol measurement | 1.52e-03 | 312 | 79 | 5 | EFO_0004612, EFO_0010351 | |
| Disease | total cholesterol measurement, high density lipoprotein cholesterol measurement | 1.59e-03 | 315 | 79 | 5 | EFO_0004574, EFO_0004612 | |
| Disease | level of Phosphatidylinositol (18:0_20:4) in blood serum | 1.73e-03 | 23 | 79 | 2 | OBA_2045158 | |
| Disease | lymphocyte count | ZFAT SLC4A7 TENM4 ALMS1 AMZ1 ZFP1 KLF14 FADS2 PAPPA ZMIZ1 MUCL3 | 1.75e-03 | 1464 | 79 | 11 | EFO_0004587 |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | 1.95e-03 | 330 | 79 | 5 | EFO_0004529, EFO_0004612 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement | 2.14e-03 | 95 | 79 | 3 | EFO_0004529, EFO_0008317, EFO_0008596 | |
| Disease | chylomicron measurement, triglyceride measurement, very low density lipoprotein cholesterol measurement | 2.21e-03 | 96 | 79 | 3 | EFO_0004530, EFO_0008317, EFO_0008596 | |
| Disease | dihomo-gamma-linolenic acid measurement | 2.38e-03 | 27 | 79 | 2 | EFO_0007763 | |
| Disease | triglyceride measurement, alcohol drinking | 2.41e-03 | 99 | 79 | 3 | EFO_0004329, EFO_0004530 | |
| Disease | triglyceride measurement, alcohol consumption measurement | 2.55e-03 | 101 | 79 | 3 | EFO_0004530, EFO_0007878 | |
| Disease | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia | 2.55e-03 | 101 | 79 | 3 | EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| INTRRIKHHFKIHVP | 41 | Q9UHT4 | |
| HSKHKNDSHIRRPCQ | 91 | A8MT66 | |
| AKLHRHQRIHTGEKP | 341 | Q86Y25 | |
| RGHSPFRQHKTKDKH | 386 | P35626 | |
| HASLQHRKPRLARKH | 81 | Q400G9 | |
| CHHRKILHRDLKPQN | 256 | Q07002 | |
| EKERHRQHHHLLQSP | 221 | Q9Y6D6 | |
| SKAPRADDHVRKHHS | 2891 | Q8TCU4 | |
| NSHKKRRNISDLNHP | 1831 | Q9UKL3 | |
| PKKTKRFPHHRLAHQ | 1971 | Q96BY7 | |
| RGHSPFRQHKTKDKH | 386 | P25098 | |
| PRRHHHQTKVFAKFS | 241 | Q9ULG1 | |
| RKHQEALHAPTDHRE | 431 | Q6DT37 | |
| LHKNRDSFLSHHPEK | 686 | P16234 | |
| RHFQHHAKPNIFHKD | 216 | O95864 | |
| KSQPKLDRNHSFRHI | 91 | Q5VWQ8 | |
| TFNLEKQNHTPRKHH | 6 | Q15233 | |
| QFSHNTRLKPPHKLH | 76 | P48060 | |
| RLEKRPSSTALHQHH | 661 | Q9UGP4 | |
| PQHHLFNFRHKPEEK | 116 | Q9NYK6 | |
| FRNKSKLGSPHHLHE | 1321 | Q8N6G6 | |
| RVHSPHKRLSHRHLK | 101 | Q9Y6F6 | |
| KFKSQQHRQGRSHHL | 231 | P43088 | |
| CRARHKKHVSPNHSS | 276 | Q68G74 | |
| HQRKKQRFLSKHISH | 31 | Q8N9F7 | |
| RHLRHPAFVKKQHNG | 441 | Q13219 | |
| QRHKTHFQHPSKLHL | 501 | Q8TCU5 | |
| HLNNPHSRHRKRIKE | 91 | O43422 | |
| TQAELRHRFHVHPKS | 276 | Q9H158 | |
| KTLQRFHHPKLSSLH | 156 | A2RU49 | |
| HRHRKKDTPVQASSH | 186 | Q8N1I0 | |
| QRKSNRHKELFALHP | 226 | Q96N67 | |
| PQRHTHTSRKKHTLE | 916 | Q9P203 | |
| NPRKHKQHHILNSSR | 76 | O60336 | |
| PKQFSRSDHLTKHAR | 261 | Q8TD94 | |
| SDHLKQHAKVHNIRP | 1036 | A0A0U1RQI7 | |
| ASHKQIHQKRKRHPE | 151 | Q9NPI7 | |
| HLAKNQGKSHRHPES | 6926 | Q8NDH2 | |
| STQENRHCKPHHQFK | 36 | Q9HAZ1 | |
| RHLSHRANNFKRHPK | 71 | Q9Y2W3 | |
| RSKDHHKHFRPIFTK | 596 | Q6ZTR5 | |
| NKHTFLQHHSDKRRP | 696 | P09619 | |
| HEQKRHCNTTRHSKP | 81 | Q3MIW9 | |
| RSKNRKRHFNAPSHV | 11 | Q9UNX3 | |
| DAFRKAKNRAVHHLH | 266 | P82675 | |
| ALLKRHHHQNEKRFT | 211 | Q9Y6M7 | |
| HHHQNEKRFTSRIPL | 216 | Q9Y6M7 | |
| PKRGHPRQNLHKHFD | 331 | O75509 | |
| PHKFVVHSHKALENR | 256 | P12755 | |
| KTKGPRHQRKHHESI | 1661 | Q8IY92 | |
| DRLTQHHRHLPQKAS | 341 | Q9BWW9 | |
| KKFRALHSNHRHSRD | 81 | Q9BRU2 | |
| KRHHVDITKKLHPNQ | 586 | Q8N1K5 | |
| FSHKANLIKHQRIHT | 221 | Q6P2D0 | |
| HKFLNANRHKTRHTG | 186 | Q8TF32 | |
| QHFHRKHCFLQKPSV | 806 | Q9Y4E5 | |
| SFKRKNHLEVHRRTH | 536 | Q96CK0 | |
| KFKHSLQAHLRIHTN | 281 | Q9P243 | |
| SLNRHIKDHSGHEPK | 116 | P52737 | |
| RSKNRKRHFNAPSHI | 11 | P61254 | |
| HNLSRHAVVHTREKP | 451 | Q99592 | |
| QHLLKHQKTHSRPAT | 176 | Q96BV0 | |
| FSQKQHLLKHQRVHR | 511 | Q96BV0 | |
| LRNKDFRHSHSPAHK | 1266 | Q6N022 | |
| HRHQTKKPIHRSLAD | 216 | Q9BY07 | |
| TEQPPRHREHKKHKH | 26 | O43290 | |
| KKAHTHVRLPNEAHN | 106 | Q9NRE2 | |
| RHHRLHTGEKPYKFN | 596 | Q6ZN06 | |
| KHVFHPKRAVFRHNL | 2221 | P78527 | |
| AHLKRHEQTHNEKSP | 516 | Q6IQ21 | |
| GKAFRRHSHLTEHQK | 221 | Q494X3 | |
| FSHQAGLIRHKRKHS | 531 | P52736 | |
| ERSHKLRKNNHHLFT | 756 | Q07157 | |
| ILKAHQHTHSKERPF | 551 | Q8N393 | |
| KAFKQRQHLAQHHRT | 241 | Q9BX82 | |
| KSFRHPSRLTHHQKI | 206 | Q969W8 | |
| KQKFQVVKHVRRHHP | 1631 | P52746 | |
| KTFSHKPSLVHHRRL | 561 | Q6ZNG1 | |
| FINHQRIHSREKPHK | 201 | Q8NCK3 | |
| KAFQHPSHLKEHVRN | 341 | Q96PQ6 | |
| PFRKRAHLTQHNRIH | 41 | Q8N8C0 | |
| NFHKHQITHTRERPF | 601 | Q9Y473 | |
| RGDNKTSHKPLHLKH | 641 | Q9ULJ6 | |
| HITQHKRIHNREKPF | 271 | Q9Y2Q1 | |
| HKKTVGHQFRNSLHL | 631 | Q9Y4I1 | |
| NHYLFKHKNHPRRSR | 66 | P29120 | |
| KHKNHPRRSRRSAFH | 71 | P29120 |